FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2142774159> ?p ?o ?g. }

• W2142774159 endingPage "S10" @default.
• W2142774159 startingPage "S5" @default.
• W2142774159 abstract "The ErbB family of receptor tyrosine kinases, of which the epidermal growth factor receptor (EGFR) is the prototype, is associated with the formation and malignant progression of most of the common solid tumors. These molecules play a key role in a complex network of signal transduction pathways that function in normal development as well as in neoplastic transformation. The EGFR and other family members are therefore promising targets for new anticancer therapies. In normal tissues, EGFR–tyrosine kinase (TK) activity is strictly controlled. However, in tumor cells, there are multiple mechanisms that can lead to increased or inappropriate EGFR-TK activity, including altered expression of EGFR, its ligand, or interacting molecules; decreased deactivation through phosphatases or downregulation; or mutation of the EGFR protein. Novel therapeutic approaches aimed at inhibiting increased EGFR-TK activity include antibodies that block the extracellular ligand-binding site, antibody or ligand fusion proteins that specifically target toxins to the tumor cells, or small-molecule TK inhibitors (TKIs) that act intracellularly to block downstream signal transduction from EGFR. Studies have shown that such blockade can lead to reduced cellular proliferation, inhibition of survival signals, and inhibition of tumor metastasis and angiogenesis. Additionally, some agents, including EGFR antibodies and TKIs such as gefitinib have been demonstrated to be effective against various human solid tumors in preclinical models and have shown activity in advanced non–small-cell lung cancer and other solid tumors." @default.
• W2142774159 created "2016-06-24" @default.
• W2142774159 creator A5000660231 @default.
• W2142774159 date "2003-09-01" @default.
• W2142774159 modified "2023-09-25" @default.
• W2142774159 title "The Impact of Gefitinib on Epidermal Growth Factor Receptor Signaling Pathways in Cancer" @default.
• W2142774159 cites W1523413020 @default.
• W2142774159 cites W1582187753 @default.
• W2142774159 cites W1599518523 @default.
• W2142774159 cites W1605302012 @default.
• W2142774159 cites W1659692600 @default.
• W2142774159 cites W1910586263 @default.
• W2142774159 cites W1931708823 @default.
• W2142774159 cites W1964321121 @default.
• W2142774159 cites W1970174108 @default.
• W2142774159 cites W1976498439 @default.
• W2142774159 cites W2004698019 @default.
• W2142774159 cites W2005204942 @default.
• W2142774159 cites W2005274511 @default.
• W2142774159 cites W2010174111 @default.
• W2142774159 cites W2014718912 @default.
• W2142774159 cites W2017261968 @default.
• W2142774159 cites W2022039302 @default.
• W2142774159 cites W2027208483 @default.
• W2142774159 cites W2027958275 @default.
• W2142774159 cites W2028415754 @default.
• W2142774159 cites W2046596676 @default.
• W2142774159 cites W2054566768 @default.
• W2142774159 cites W2058586542 @default.
• W2142774159 cites W2058839845 @default.
• W2142774159 cites W2064047613 @default.
• W2142774159 cites W2074094034 @default.
• W2142774159 cites W2080414061 @default.
• W2142774159 cites W2098924026 @default.
• W2142774159 cites W2101862196 @default.
• W2142774159 cites W2104431314 @default.
• W2142774159 cites W2129040492 @default.
• W2142774159 cites W2130840817 @default.
• W2142774159 cites W2132080332 @default.
• W2142774159 cites W2134933569 @default.
• W2142774159 cites W2146404049 @default.
• W2142774159 cites W2172066072 @default.
• W2142774159 cites W2314166141 @default.
• W2142774159 cites W26155307 @default.
• W2142774159 doi "https://doi.org/10.3816/clc.2003.s.009" @default.
• W2142774159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14641988" @default.
• W2142774159 hasPublicationYear "2003" @default.
• W2142774159 type Work @default.
• W2142774159 sameAs 2142774159 @default.
• W2142774159 citedByCount "3" @default.
• W2142774159 countsByYear W21427741592012 @default.
• W2142774159 countsByYear W21427741592013 @default.
• W2142774159 crossrefType "journal-article" @default.
• W2142774159 hasAuthorship W2142774159A5000660231 @default.
• W2142774159 hasConcept C101544691 @default.
• W2142774159 hasConcept C121608353 @default.
• W2142774159 hasConcept C126322002 @default.
• W2142774159 hasConcept C170493617 @default.
• W2142774159 hasConcept C2776362946 @default.
• W2142774159 hasConcept C2777506169 @default.
• W2142774159 hasConcept C2779438470 @default.
• W2142774159 hasConcept C2780394083 @default.
• W2142774159 hasConcept C2780580887 @default.
• W2142774159 hasConcept C42362537 @default.
• W2142774159 hasConcept C502942594 @default.
• W2142774159 hasConcept C62478195 @default.
• W2142774159 hasConcept C71924100 @default.
• W2142774159 hasConcept C86803240 @default.
• W2142774159 hasConcept C95444343 @default.
• W2142774159 hasConceptScore W2142774159C101544691 @default.
• W2142774159 hasConceptScore W2142774159C121608353 @default.
• W2142774159 hasConceptScore W2142774159C126322002 @default.
• W2142774159 hasConceptScore W2142774159C170493617 @default.
• W2142774159 hasConceptScore W2142774159C2776362946 @default.
• W2142774159 hasConceptScore W2142774159C2777506169 @default.
• W2142774159 hasConceptScore W2142774159C2779438470 @default.
• W2142774159 hasConceptScore W2142774159C2780394083 @default.
• W2142774159 hasConceptScore W2142774159C2780580887 @default.
• W2142774159 hasConceptScore W2142774159C42362537 @default.
• W2142774159 hasConceptScore W2142774159C502942594 @default.
• W2142774159 hasConceptScore W2142774159C62478195 @default.
• W2142774159 hasConceptScore W2142774159C71924100 @default.
• W2142774159 hasConceptScore W2142774159C86803240 @default.
• W2142774159 hasConceptScore W2142774159C95444343 @default.
• W2142774159 hasLocation W21427741591 @default.
• W2142774159 hasLocation W21427741592 @default.
• W2142774159 hasOpenAccess W2142774159 @default.
• W2142774159 hasPrimaryLocation W21427741591 @default.
• W2142774159 hasRelatedWork W1837617056 @default.
• W2142774159 hasRelatedWork W2024202398 @default.
• W2142774159 hasRelatedWork W2031328554 @default.
• W2142774159 hasRelatedWork W2055903396 @default.
• W2142774159 hasRelatedWork W2139819066 @default.
• W2142774159 hasRelatedWork W2142436130 @default.
• W2142774159 hasRelatedWork W2142774159 @default.
• W2142774159 hasRelatedWork W2330895387 @default.
• W2142774159 hasRelatedWork W2999353341 @default.
• W2142774159 hasRelatedWork W3029235022 @default.

• next